- Home
- SXTC vs TCBP Comparison
SXTC vs TCBP Comparison
Compare SXTC & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- TCBP
- Stock Information
- Founded
- SXTC 2005
- TCBP 2013
- Country
- SXTC China
- TCBP United Kingdom
- Employees
- SXTC N/A
- TCBP N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SXTC Health Care
- TCBP Health Care
- Exchange
- SXTC Nasdaq
- TCBP Nasdaq
- Market Cap
- SXTC 2.5M
- TCBP 3.0M
- IPO Year
- SXTC 2019
- TCBP 2022
- Fundamental
- Price
- SXTC $0.39
- TCBP $0.68
- Analyst Decision
- SXTC
- TCBP
- Analyst Count
- SXTC 0
- TCBP 0
- Target Price
- SXTC N/A
- TCBP N/A
- AVG Volume (30 Days)
- SXTC 206.0K
- TCBP 3.0M
- Earning Date
- SXTC 01-01-0001
- TCBP 11-29-2024
- Dividend Yield
- SXTC N/A
- TCBP N/A
- EPS Growth
- SXTC N/A
- TCBP N/A
- EPS
- SXTC N/A
- TCBP N/A
- Revenue
- SXTC $1,928,497.00
- TCBP N/A
- Revenue This Year
- SXTC N/A
- TCBP N/A
- Revenue Next Year
- SXTC N/A
- TCBP N/A
- P/E Ratio
- SXTC N/A
- TCBP N/A
- Revenue Growth
- SXTC N/A
- TCBP N/A
- 52 Week Low
- SXTC $0.37
- TCBP $0.56
- 52 Week High
- SXTC $6.39
- TCBP $138.00
- Technical
- Relative Strength Index (RSI)
- SXTC 29.34
- TCBP 23.01
- Support Level
- SXTC $0.45
- TCBP $1.05
- Resistance Level
- SXTC $0.51
- TCBP $1.25
- Average True Range (ATR)
- SXTC 0.06
- TCBP 0.22
- MACD
- SXTC -0.01
- TCBP 0.06
- Stochastic Oscillator
- SXTC 5.97
- TCBP 10.36
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.